BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30803559)

  • 1. Embryonal rhabdomyosarcoma in a patient with a germline CBL pathogenic variant.
    Ji J; Navid F; Hiemenz MC; Kaneko M; Zhou S; Saitta SC; Biegel JA
    Cancer Genet; 2019 Feb; 231-232():62-66. PubMed ID: 30803559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of splenomegaly in CBL syndrome.
    Coe RR; McKinnon ML; Tarailo-Graovac M; Ross CJ; Wasserman WW; Friedman JM; Rogers PC; van Karnebeek CDM
    Eur J Med Genet; 2017 Jul; 60(7):374-379. PubMed ID: 28414188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline mutation of CBL is associated with moyamoya disease in a child with juvenile myelomonocytic leukemia and Noonan syndrome-like disorder.
    Hyakuna N; Muramatsu H; Higa T; Chinen Y; Wang X; Kojima S
    Pediatr Blood Cancer; 2015 Mar; 62(3):542-4. PubMed ID: 25283271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NRAS associated RASopathy and embryonal rhabdomyosarcoma.
    Garren B; Stephan M; Hogue JS
    Am J Med Genet A; 2020 Jan; 182(1):195-200. PubMed ID: 31697451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo mutations in CBL causing early-onset paediatric moyamoya angiopathy.
    Guey S; Grangeon L; Brunelle F; Bergametti F; Amiel J; Lyonnet S; Delaforge A; Arnould M; Desnous B; Bellesme C; Hervé D; Schwitalla JC; Kraemer M; Tournier-Lasserve E; Kossorotoff M
    J Med Genet; 2017 Aug; 54(8):550-557. PubMed ID: 28343148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel, germline, deactivating CBL variant p.L493F alters domain orientation and is associated with multiple childhood cancers.
    Norris GA; Tsai AC; Schneider KW; Wu YH; Caulfield T; Green AL
    Cancer Genet; 2021 Jun; 254-255():18-24. PubMed ID: 33550024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Diversity and Associated Phenotypic Spectrum of Germline CBL Mutations.
    Martinelli S; Stellacci E; Pannone L; D'Agostino D; Consoli F; Lissewski C; Silvano M; Cencelli G; Lepri F; Maitz S; Pauli S; Rauch A; Zampino G; Selicorni A; Melançon S; Digilio MC; Gelb BD; De Luca A; Dallapiccola B; Zenker M; Tartaglia M
    Hum Mutat; 2015 Aug; 36(8):787-96. PubMed ID: 25952305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline CBL mutation associated with a noonan-like syndrome with primary lymphedema and teratoma associated with acquired uniparental isodisomy of chromosome 11q23.
    Hanson HL; Wilson MJ; Short JP; Chioza BA; Crosby AH; Nash RM; Marks KJ; Mansour S
    Am J Med Genet A; 2014 Apr; 164A(4):1003-9. PubMed ID: 24458550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RASopathy-associated CBL germline mutations cause aberrant ubiquitylation and trafficking of EGFR.
    Brand K; Kentsch H; Glashoff C; Rosenberger G
    Hum Mutat; 2014 Nov; 35(11):1372-81. PubMed ID: 25178484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants.
    Baccelli F; Leardini D; Muratore E; Messelodi D; Bertuccio SN; Chiriaco M; Cancrini C; Conti F; Castagnetti F; Pedace L; Pession A; Yoshimi A; Niemeyer C; Tartaglia M; Locatelli F; Masetti R
    Hum Genomics; 2022 Sep; 16(1):40. PubMed ID: 36123612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia.
    Niemeyer CM; Kang MW; Shin DH; Furlan I; Erlacher M; Bunin NJ; Bunda S; Finklestein JZ; Gorr TA; Mehta P; Schmid I; Kropshofer G; Corbacioglu S; Lang PJ; Klein C; Schlegel PG; Heinzmann A; Schneider M; Starý J; van den Heuvel-Eibrink MM; Hasle H; Locatelli F; Sakai D; Archambeault S; Chen L; Russell RC; Sybingco SS; Ohh M; Braun BS; Flotho C; Loh ML
    Nat Genet; 2010 Sep; 42(9):794-800. PubMed ID: 20694012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia.
    Pérez B; Mechinaud F; Galambrun C; Ben Romdhane N; Isidor B; Philip N; Derain-Court J; Cassinat B; Lachenaud J; Kaltenbach S; Salmon A; Désirée C; Pereira S; Menot ML; Royer N; Fenneteau O; Baruchel A; Chomienne C; Verloes A; Cavé H
    J Med Genet; 2010 Oct; 47(10):686-91. PubMed ID: 20543203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile myelomonocytic leukemia due to a germline CBL Y371C mutation: 35-year follow-up of a large family.
    Pathak A; Pemov A; McMaster ML; Dewan R; Ravichandran S; Pak E; Dutra A; Lee HJ; Vogt A; Zhang X; Yeager M; Anderson S; Kirby M; ; ; Caporaso N; Greene MH; Goldin LR; Stewart DR
    Hum Genet; 2015 Jul; 134(7):775-87. PubMed ID: 25939664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paternal uniparental disomy with segmental loss of heterozygosity of chromosome 11 are hallmark characteristics of syndromic and sporadic embryonal rhabdomyosarcoma.
    Robbins KM; Stabley DL; Holbrook J; Sahraoui R; Sadreameli A; Conard K; Baker L; Gripp KW; Sol-Church K
    Am J Med Genet A; 2016 Dec; 170(12):3197-3206. PubMed ID: 27589201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood Rhabdomyosarcoma in Association With a RASopathy Clinical Phenotype and Mosaic Germline SOS1 Duplication.
    Salem B; Hofherr S; Turner J; Doros L; Smpokou P
    J Pediatr Hematol Oncol; 2016 Nov; 38(8):e278-e282. PubMed ID: 27258033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noonan syndrome, the SOS1 gene and embryonal rhabdomyosarcoma.
    Jongmans MC; Hoogerbrugge PM; Hilkens L; Flucke U; van der Burgt I; Noordam K; Ruiterkamp-Versteeg M; Yntema HG; Nillesen WM; Ligtenberg MJ; van Kessel AG; Kuiper RP; Hoogerbrugge N
    Genes Chromosomes Cancer; 2010 Jul; 49(7):635-41. PubMed ID: 20461756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype.
    Martinelli S; De Luca A; Stellacci E; Rossi C; Checquolo S; Lepri F; Caputo V; Silvano M; Buscherini F; Consoli F; Ferrara G; Digilio MC; Cavaliere ML; van Hagen JM; Zampino G; van der Burgt I; Ferrero GB; Mazzanti L; Screpanti I; Yntema HG; Nillesen WM; Savarirayan R; Zenker M; Dallapiccola B; Gelb BD; Tartaglia M
    Am J Hum Genet; 2010 Aug; 87(2):250-7. PubMed ID: 20619386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adults with germline CBL mutation complicated with juvenile myelomonocytic leukemia at infancy.
    Muraoka M; Okuma C; Kanamitsu K; Ishida H; Kanazawa Y; Washio K; Seki M; Kato M; Takita J; Sato Y; Ogawa S; Tsukahara H; Oda M; Shimada A
    J Hum Genet; 2016 Jun; 61(6):523-6. PubMed ID: 26911351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrops, fetal pleural effusions and chylothorax in three patients with CBL mutations.
    Bülow L; Lissewski C; Bressel R; Rauch A; Stark Z; Zenker M; Bartsch O
    Am J Med Genet A; 2015 Feb; 167A(2):394-9. PubMed ID: 25358541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RRAS2 pathogenic variant (c.67G>T; p. Gly23Cys) produces Noonan syndrome with embryonal rhabdomyosarcoma.
    Zeng L; Wang J; Zhu H; Huang Y; Deng Y; Wei P; Nie J; Tang B; Chen A; Zhu S
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2313. PubMed ID: 37942564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.